AOTI Full Year 2024 Earnings: US$0.018 loss per share (vs US$0.099 loss in FY 2023)

AOTI (LON:AOTI) Full Year 2024 Results

Key Financial Results

• Revenue: US$58.4m (up 33% from FY 2023).
• Net loss: US$1.76m (loss narrowed by 79% from FY 2023).
• US$0.018 loss per share (improved from US$0.099 loss in FY 2023).

Our free stock report includes 2 warning signs investors should be aware of before investing in AOTI. Read for free now.

All figures shown in the chart above are for the trailing 12 month (TTM) period

AOTI Earnings Insights

The primary driver behind last 12 months revenue was the Veterans Administration segment contributing a total revenue of US$34.4m (59% of total revenue). The largest operating expense was General & Administrative costs, amounting to US$25.1m (47% of total expenses). Explore how AOTI's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 5.8% growth forecast for the Medical Equipment industry in the United Kingdom.

Performance of the British Medical Equipment industry.

The company's shares are down 3.0% from a week ago.

Risk Analysis

You should learn about the 2 warning signs we've spotted with AOTI.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.